Cargando…
Low-dose spironolactone ameliorates adipose tissue inflammation and apoptosis in letrozole-induced PCOS rat model
BACKGROUND OF STUDY: Globally, many reproductive aged women are affected by polycystic ovarian syndrome (PCOS), which is a common endocrine and metabolic disorder that is linked with adipose dysfunction and chronic low-grade inflammation. Spironolactone (SPL), a mineralocorticoid receptor blocker ha...
Autores principales: | Areloegbe, Stephanie E., Peter, Mmenyene U., Oyeleke, Mosunmola B., Olaniyi, Kehinde S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454226/ https://www.ncbi.nlm.nih.gov/pubmed/36071485 http://dx.doi.org/10.1186/s12902-022-01143-y |
Ejemplares similares
-
Modulation of GABA by sodium butyrate ameliorates hypothalamic inflammation in experimental model of PCOS
por: Eepho, Oony-Iye, et al.
Publicado: (2023) -
Short chain fatty acid, acetate restores ovarian function in experimentally induced PCOS rat model
por: Olaniyi, Kehinde S., et al.
Publicado: (2022) -
Altered vitamin D(3) metabolism in the ovary and periovarian adipose tissue of rats with letrozole-induced PCOS
por: Grzesiak, Malgorzata, et al.
Publicado: (2020) -
ETA-mediated anti-TNF-α therapy ameliorates the phenotype of PCOS model induced by letrozole
por: Lang, Qin, et al.
Publicado: (2019) -
SAT379 Potassium Levels in Women with PCOS Using Spironolactone for Long-term
por: Oliveira, Thais Areias, et al.
Publicado: (2023)